curriculum vitae - mail :: welcome to horde · curriculum vitae - dianne o’connell – january...

Curriculum Vitae - Dianne O’Connell – January 2012 of 26

Curriculum Vitae

Dianne Lesley O’Connell

Current Position Senior Epidemiologist Cancer Epidemiology Research Unit Cancer Council

Contact Details PO Box 572 Kings Cross, NSW, 1340 Australia

Telephone 61 (0)2 9334 1768 Fax 61 (0)2 8302 3550 E-mail [email protected]

Education

Institution and Location Degree Year(s) Field of Study

University of Newcastle PhD 1984 Statistics

University of Newcastle BMaths (Hons) 1980 Mathematics

Positions and Employment 1986-1990 Lecturer in Biostatistics, Centre for Clinical Epidemiology and Biostatistics,

University of Newcastle 1991-1994 Senior Lecturer in Biostatistics, Centre for Clinical Epidemiology and

Biostatistics, University of Newcastle 1994-1995 Research Academic, Centre for Clinical Epidemiology and Biostatistics,

University of Newcastle 1995-1997 Research Academic, Discipline of Clinical Pharmacology, University of

Newcastle 1998-1999 Senior Brawn Research Fellow, Discipline of Clinical Pharmacology,

University of Newcastle 2000 Research Academic, Discipline of Clinical Pharmacology, University of

Newcastle 2000 Senior Lecturer in Statistics, School of Mathematics and Physical Sciences,

University of Newcastle 2001- Senior Epidemiologist, Cancer Research Division, The Cancer Council NSW 2001-2009 Conjoint Associate Professor, Faculty of Medicine and Health Sciences,

University of Newcastle 2009- Conjoint Professor, School of Medicine and Public Health, Faculty of Health,

University of Newcastle 2010- Conjoint Professor, School of Public Health and Community Medicine,

University of New South Wales 2011- Honorary Professor, Sydney Medical School – Public Health, University of

Sydney


Honours 2001 The Thomas C Chalmers M.D. Excellence Award ($500 US). In recognition

of the presentation: Henry D, Moxey A, O’Connell D (2001). Agreement between randomised and non-randomised studies – the effects of bias and confounding. 9th Cochrane Colloquium, 9-13 October 2001, Lyon, France

Prizes 1976 I.C.L. Prize for Numerical Mathematics 1977 Prize for Mathematics II 1978 Prize for Mathematics III 1978 Australian Federation of University Women - N.S.W. Prize for best woman

student in Mathematics III Scholarships 1980-83 Commonwealth of Australia Postgraduate Award Fellowships 1983-86 National Health and Medical Research Council of Australia Neil Hamilton

Fairley Fellowship, 1998-99 Brawn Career Development Fellowship, Faculty of Medicine and Health

Sciences, University of Newcastle Memberships of Learned Societies Biometrics Society (1985-2008) Statistical Society of Australia (1985-) International Society for Technology Assessment in Health Care (1995-2000) Australasian Epidemiological Association (2005-) International Epidemiological Association (2010-) Experience, consulting and service 1980-83 University of Newcastle, Australia 1980-1983 Member of the Population Research Group in the Faculty of Medicine 1980-81 Member of the Steering Committee of the Hunter Region Childhood Smoking

Prevention Study 1979, 1980 Attended the annual workshop in clinical epidemiology and health services

research organised jointly by University of Newcastle, Westmead Hospital, University of Sydney and Macquarie University

1983-85 University of North Carolina at Chapel Hill, USA 1983-85 Member of the Journal Club at LRC Central Patient Registry and

Coordinating Centre 1983-85 Statistical reviewer for publications-in-preparation, research proposals and

analysis protocols at LRC Central Patient Registry and Coordinating Centre 1983-85 Attended graduate courses offered by the Departments of Biostatistics and

Epidemiology. These included Survival Analysis, Cardiovascular Disease Epidemiology, Cancer Epidemiology, Statistical Computing, Large Number Theory, and Analysis of Longitudinal Data


1986-2000 University of Newcastle, Australia 1986-94 Conducted site and interview visits for the INCLEN Programme 1987-94 Attended annual INCLEN meetings 1989-94 Convenor of Sample Size Working Group within INCLEN Biostatistics

Subcommittee 1988-94 Member of Multicentre Collaborative Study of Risk Factors for

Cardiovascular Disease in INCLEN team 1989-93 Conducted Vivas for Year 4 Population Medicine 1986-93 Carried out interviews for prospective medical students 1988-94 Member of Board of Studies in Clinical Epidemiology and Biostatistics 1988-94 Member of Advisory Committee for the Centre for Clinical Epidemiology and

Biostatistics 1989 Consultant to the Chelmsford Royal Commission Statistical referee for Biometrics, Medical Journal of Australia, NH&MRC

Public Health Research and Development Committee Grants, Victorian Health Promotion Foundation, Australian Journal of Public Health

1986-2000 Statistical consultant and collaborator on projects undertaken by members of the Medical Faculty including the analysis of the student admissions data, a study of risk factors for nosocomial infection in Royal Newcastle Hospital, a study of reasons for failure to become an organ donor, a WHO study of an education program to improve fifth year medical student’s performance, a study of which medical graduates choose to practice in rural areas and why, studies carried out by the clinical pharmacology group

1991-94 Member of the Musculoskeletal Research Group, Newcastle 1993 Technical adviser to WHO Human Reproduction Programme to conduct

workshop on research methods in Ho Chi Minh City, Vietnam 1993, 1995 Adviser to Australian Medical Benefits Advisory Committee 1994-2000 Consultant to the Health Insurance Commission, Australia 1995-97 Member of Prescribing Education Reference Group organised by the Health

Insurance Commission 1995-2000 Statistical Adviser to Hunter Area Research Ethics Committee 1995 Consultant to Therapeutic Goods Administration, Department of Human

Services and Health 1995- Member of Statistics Methods Working Group, Applicability and

Recommendations Methods Working Group; Depression, Anxiety and Neurosis Review Group; and Musculoskeletal Review Group, Cochrane Collaboration

1996-97 Member of the SEG Monitoring Subcommittee, General Practice Branch, Commonwealth Department of Health and Family Services which produced General Practice in Australia: 1996

1996-2000 Statistical consultant to the Hunter Urban Division of General Practice 1997-99 External Evaluator for Hunter Urban Division of General Practice Diabetes

Shared Care Project funded by General Practice Branch, Commonwealth Department of Health and Family Services

1997-99 External Evaluator for Hunter Urban Division of General Practice Diabetes Shared Care Project funded by General Practice Branch, Commonwealth Department of Health and Family Services

1999-2000 Member of the National Prescribing Service Evaluation Working Group 1999-2000 Member of editorial committee for General Practice in Australia: 2000 1999-2000 Assessor for NHMRC project grants 2000 Reviewer for Health Research Board Fellowship, Republic of Ireland 1999-2000 Local evaluator for After Hours Primary Medical Care Trial for Hunter Urban

Division of General Practice funded by Commonwealth Department of Health and Aged Care


2001 – 2010 Cancer Council NSW 2001- Statistical reviewer for Medical Journal of Australia 2001- Reviewer for Australian New Zealand Journal of Public Health 2001- Assessor for NHMRC project grants 2001-2002 Member of the National Prescribing Service Evaluation Working Group 2001- Reviewer for Canadian Medical Association Journal 2001- Assessor for National Ranking of Cancer Research Grant Applications, The

Cancer Councils in Australia 2001- Reviewer for Canadian Pharmacists Journal 2006-2007 Member of AGITG data monitoring committee 2006- Executive Editor and statistical reviewer for the Cochrane Breast Cancer

Group 2006- Member of Cancer Institute NSW Oncology Group – Lung 2006 Member of Public Health Review panel for NHMRC project grants 2007 Examiner University of Sydney 2007 Examiner University of Newcastle 2008 Assessor for Health Research Council of New Zealand research applications 2008- Reviewer for Asian Pacific Journal of Clinical Oncology 2008- 2010- 2010 2011- 2011- 2011-

Member of Cancer Institute NSW Cancer Information Registries Advisory Committee Member of the Epidemiology Reference Group for the International Cancer Benchmarking/Improvement Partnership Assessor for Research Promotion Foundation of Cyprus grants Member of the Medical Services Advisory Committee (MSAC) Evaluation Sub-Committee (ESC) for Commonwealth Department of Health and Ageing Assessor for Prostate Cancer Foundation of Australia grant applications

Major research achievements Prof O’Connell is a biostatistician/epidemiologist with extensive experience in designing and analysing epidemiological studies and randomised controlled trials. She also specialises in evidence-based health care and health services research. She has extensive experience in analysing large, routinely collected datasets including those collected by the Medical Benefits Scheme, the Pharmaceutical Benefits Scheme, the NSW Central Cancer Registry and the NSW Admitted Patient Data Collection. Since joining the Cancer Council in 2001, Prof O’Connell has headed up studies on the variation in the management and treatment of major cancers in NSW and the analysis of data from the NSW Central Cancer Registry. This work has resulted in the production and wide circulation of a number of descriptive epidemiology reports and invitations to speak at national cancer conferences and meetings. Prof O’Connell is an active member of the Cochrane Collaboration with involvement in methods working groups and review groups including being a member of the Executive for the Breast Cancer Group. She is an author of a number of systematic reviews in the Cochrane Library. Peer-reviewed publications 1981-1990 1. Hardes GR, Alexander HM, Dobson AJ, Lloyd DM, O’Connell D, Purcell I, Leeder SR.

Cigarette smoking and drug use in schoolchildren in the Hunter region, New South


Wales: I – Tobacco, alcohol and analgesic use in 10 to 12 year old primary schoolchildren (1979). Med J Aust 1981; 1:579-81.

2. O’Connell DL, Alexander HM, Dobson AJ, Lloyd DM, Hardes GR, Springthorpe HJ, Leeder SR. Cigarette smoking and drug use in schoolchildren: II – Factors associated with smoking. Int J Epidemiol 1981; 10:223-31.

3. Lloyd DM, Alexander HM, Callcott R, Dobson AJ, Hardes GR, O’Connell DL, Leeder SR. Cigarette smoking and drug use in schoolchildren: III – Evaluation of a smoking prevention education programme. Int J Epidemiol 1982; 12:51-8.

4. Alexander HM, Callcott R, Dobson AJ, Hardes GR, Lloyd DM, O’Connell DL, Leeder SR. Cigarette smoking and drug use in schoolchildren: IV – Factors associated with changes in smoking behaviour. Int J Epidemiol 1982; 12:59-66.

5. Webb KL, Dobson AJ, Tupling HE, Harris GW, O’Connell DL, Atkinson J, Sulway MJ, Leeder SR. Evaluation of a diabetes education programme. Aust NZ J Med 1982; 12:153-60.

6. O’Connell DL, Dobson AJ. General observer-agreement measures on individual subjects and groups of subjects. Biometrics 1984; 40:973-83.

7. Webb KL, Dobson AJ, O’Connell DL, Tupling HE, Harris GW, Moxon JA, Sulway MJ, Leeder SR. Dietary compliance among insulin dependent diabetics. J Chronic Dis 1984; 37:633-43.

8. Dobson AJ, Gibberd RW, Leeder SR, O’Connell DL. Occupational differences in ischemic heart disease mortality and risk factors in Australia. Am J Epidemiol 1985; 122:283-90.

9. O’Connell DL, Hulka B, Chambless L, Wilkinson W, Deubner D. Cigarette Smoking, Alcohol Consumption and Breast Cancer Risk. J Nat Cancer Inst 1987; 78:229-34.

10. Agrez MV, Spagnolo D, Harvey J, House AK, O’Connell DL. Prognostic significance of lymphatic permeation in Dukes’ B colorectal cancer. ANZ J Surgery 1988; 58:39-42.

11. Manwarring L, O’Connell DL, Zardawi IM, Dobson AJ, Bhagwandeen BS. Morphometric analysis of coronary artery stenosis: An accuracy and reliability study. J Path 1988; 156:111-9.

12. O’Connell DL, Heller RF, Roberts DC, Allen J, Knapp J, Steele PL. A twin study of genetic and environmental effects on lipid levels. Gen Epidemiol 1988; 5:323-41.

13. Heller RF, O’Connell DL, Roberts DC, Allen J, Knapp J, Steele PL. Lifestyle factors in monozygotic and dizygotic twins. Gen Epidemiol 1988; 5:311-21.

14. Mitchell AS, Henry DA, O’Connell DL. Patients as a direct source of information on adverse drug reactions. Br Med J 1988; 297:891-3.

15. Henry DA, O’Connell DL. Effects of fibrinolytic inhibitors on mortality from upper gastrointestinal haemorrhage. Br Med J 1989; 298:1142-6.

16. Lord S, Sawyer B, Pond D, O’Connell D et al. Interrater reliability of computer-assisted scoring of breathing during sleep. Sleep 1989; 12:550-8.

17. Cowan LD, O’Connell DL, Criqui MH et al. Cancer mortality and lipid and lipoprotein levels. The Lipid Research Clinics Program Mortality Follow-up Study. Am J Epidemiol 1990; 131:468-82.

1991-2000 18. Lord S, Sawyer B, O’Connell DL, et al. Night to night variability of disturbed breathing

during sleep in an elderly community sample. Sleep 1991; 14:252-8. 19. Heller CA, Knapp J, Halliday J, O’Connell D, Heller RF. Failure to demonstrate

contrast nephrotoxicity. Med J Aust 1991; 155:329-32. 20. Kinlay S, O’Connell DL, Evans D, Francis L. Validity of estimating heart disease

reduction from a Framingham logistic equation. J Clin Epidemiol 1992; 45:553-60. 21. Hibberd AD, Pearson IY, McCosker CJ, Chapman JR, Macdonald GJ, Thompson JF,

O’Connell DL, et al. The potential for cadaveric organ retrieval in New South Wales. Br Med J 1992; 304:1339-43.


22. Walker R, Heller R, Redman S, O’Connell D, Boulton J. Reduction of ischaemic heart disease risk markers in the teenage children of heart attack patients. Prev Med 1992; 21:616-29.

23. Powis DA, Waring TC, Bristow T, O’Connell DL. The structured interview as a tool for predicting premature withdrawal from medical school. Aust NZ J Med 1992; 22:692-8.

24. INCLEN Multicentre Collaborative Group. Risk factors for cardiovascular disease in the developing world. A multicentre collaborative study in the International Clinical Epidemiology Network (INCLEN). J Clin Epidemiol 1992; 45:841-7.

25. Kruse H, Johnson A, O’Connell D, Clarke T. Administering non-restricted medications in hospital: the implications and cost of using two nurses. Aust Clin Rev 1992; 12:77-83.

26. Hibberd AD, Pearson IY, McCosker CJ, Chapman JR, Macdonald GJ, Thompson JF, O’Connell DL, et al. Measurement of the potential for cadaveric organ retrieval in New South Wales, Australia. Transplant Proc 1993; 25:1565-6.

27. Kong X, Fang HT, Jiang GQ, Zhai SZ, O’Connell DL, Brewster DR. Chinese herbal treatment of acute bronchiolitis. Arch Dis Childhood 1993; 68:468-71.

28. Rydon L, Bhagwandeen BS, O’Connell DL, Dobson AJ. Coronary artery stenosis in an Australian population. Pathology 1993; 25:15-9.

29. Duggan J, O’Connell D, Heller RF, Ghosh H. Causes of hospital acquired septicemia – a case-control study. Quarterly J Med 1993; 86:479-83.

30. Silove D, Manicavasagar V, O’Connell D, Blaszczynski A, Wagner R, Henry J. The development of the Separation Anxiety Symptom Inventory (SASI). Aust NZ J Psych 1993; 27:477-88.

31. Silove D, Manicavasagar V, O’Connell D, Blaszczynski A, Wagner R. Reported early separation anxiety symptoms in patients with panic and generalised anxiety disorders. Aust NZ J Psych 1993; 27:489-94.

32. Duffy DL, O’Connell DL, Heller RF, Martin NG. Risk factors for atherosclerosis in twins. Gen Epidemiol 1993; 10:557-62.

33. Brewster DR, Pyakalyia T, Hiawalyer G, O’Connell DL. Evaluation of the ARI Programme: a health facility survey in Simbu, Papua-New Guinea. PNG Med J 1993; 36:285-96.

34. Kinlay S, O’Connell D, Evans D, Halliday J. A new method of estimating cost-effectiveness of cholesterol reduction therapy for prevention of heart disease. Pharmaco Economics 1994; 5:238-48.

35. Kinlay S, O’Connell D, Evans D, Halliday J. The cost-effectiveness of different blood cholesterol lowering strategies in the prevention of coronary heart disease. Aust J Pub Health 1994; 18:105-10.

36. Heller R, Walker R, Boyle C, O’Connell D, Rusakaniko S, Dobson AJ. A randomised controlled trial of a dietary advice program among relatives of heart attack victims. Med J Aust 1994; 161:529-31.

37. Mitchell AS, Henry DA, Hennrikus D, O’Connell DL. Adverse drug reactions: Can consumers provide early warnings? Pharmacoepidemiology and Drug Safety 1994; 3:257-64.

38. INCLEN Multicentre Collaborative Group. Socio-economic status and risk factors for cardiovascular disease: a multicentre collaborative study in the International Clinical Epidemiology Network (INCLEN). J Clin Epidemiol 1994; 47:1401-9.

39. Duffy DL, Manicavasagar V, O’Connell D, Silove D, Tennant C, Langelludecke P. Type A personality in Australian twins. Behavior Genetics 1994; 24:469-75.

40. Lau EMC, Gillespie WG, Valenti L, O’Connell D. The seasonality of hip fracture and its relationship with weather conditions in New South Wales, Australia. Aust J Pub Health 1995; 19:76-80.

41. Hazell P, O’Connell D, Heathcote D, Robertston J, Henry D. Efficacy of tricyclic drugs in treating child and adolescent depression: a meta-analysis. Br Med J 1995; 310:897-901.


42. Buckley NA, Dawson AH, Whyte IM, O’Connell DL. Relative toxicity of benzodiazepines in overdose. Br Med J 1995; 310:219-21.

43. O’Connell D, Henry D. Trial of streptokinase in ischaemic stroke. Letters. Lancet 1995; 345:1053.

44. Foy A, O’Connell D, Henry D, et al. Benzodiazepine use as a cause of cognitive impairment in elderly hospital inpatients. A study of subjects with normal cognitive function at entry. J. Geront: Medical Sciences 1995; 50A:M99-M106.

45. Gillespie WJ, Pekarsky B, O’Connell DL. Evaluation of new technologies for total hip replacement: economic modelling and clinical trials. J Bone Joint Surg 1995; 77-B:528-33.

46. O’Connell DL, Halliday J, Heller RF, Roberts DC et al. Genetic and environmental effects on response of blood cholesterol to dietary change: a twin study. Nutr, Metab and CVD 1995; 5:63-9.

47. Thompson JF, McCosker CS, Hibberd AD, Chapman JR, MacDonald GJ, O’Connell DL et al. Identification of the cadaveric potential organ donors in New South Wales. Anaesth Intens Care 1995; 23:75-80.

48. Lau EMC, Egger P, Coggon D, Cooper C, Valenti L, O’Connell D. Low back pain in Hong Kong: prevalence and characteristics compared with Britain. J Epidemiol and Community Health 1995; 49:492-94.

49. Rolfe IE, Pearson S, O’Connell DL, Dickinson J. Finding solutions to the rural doctor shortage: the roles of selection versus undergraduate medical education at Newcastle. Aust NZ J Med 1995; 25:512-17.

50. Silove D, Manicavasagar V, O’Connell D, Morris-Yates A. Genetic factors in early separation anxiety: implications for the genesis of adult anxiety disorders. Acta Psychiatr Scand 1995; 92:17-24.

51. Buckley NA, Smith AJ, Dosen P, O’Connell DL. Effects of catecholamines and diazepam in chloroquine poisoning in barbiturate anaesthetised rats. Human & Experimental Toxicology 1996; 15: 909-14.

52. Gillespie WJ, Henry DA, O’Connell DL, et al. Development of hematopoietic cancers after implantation of total joint replacement. Clinical Orthopaedics 1996; 329S: S290-S296.

53. Buckley NA, O’Connell DL, Whyte IM, Dawson AH. Inter-rater agreement in the measurement of QRS interval in tricyclic antidepressant overdose: implications for monitoring and research. Ann Emerg Med 1996; 28: 515-9.

54. Gillespie WJ, Henry DA, O’Connell DL, Robertson J. Vitamin D and Vitamin D analogues in the prevention of fractures in involutional and post-menopausal osteoporosis. In: Gillespie WJ, Madhok R, Murray GD, Robinson CM, Swiontkowski MF (eds.) Musculoskeletal Injuries Module of The Cochrane Database of Systematic Reviews , [updated 02 June 1997]. Available in The Cochrane Library [database on disk and CDROM]. The Cochrane Collaboration; Issue 3. Oxford: Update Software; 1997. Updated quarterly.

55. Henry D, Robertson J, O’Connell D, Gillespie W. A systematic review of the skeletal effects of estrogen therapy in post-menopausal women I. An assessment of the quality of randomised trials published between 1977 and 1995. Climacteric 1998; 1: 92-111.

56. O’Connell D, Robertson J, Henry D, Gillespie W. A systematic review of the skeletal effects of estrogen therapy in post-menopausal women II. An assessment of treatment effects. Climacteric 1998; 1: 112-123.

57. Kinlay JR, O’Connell DL, Kinlay S. Incidence of mastitis in breastfeeding women during the six months following delivery: a prospective cohort study. Med J Aust 1998; 169: 310-312.

58. O’Connell DL, Henry D, Tomlins R. Randomised controlled trial of effect of feedback on general practitioners’ prescribing in Australia. BMJ 1999;318:507-511.

59. Nikolajevic-Sarunac J, Henry DA, O’Connell DL, Robertson J. Effects of information framing on the intentions of family physicians to prescribe long-term hormone replacement therapy. J Gen Intern Med 1999;14:591-598.


60. McGettigan P, Sly K, O’Connell D, Hill S, Henry D. The effect of information framing on the practices of physicians. A systematic review of the published literature. J Gen Intern Med 1999;14:633-642.

61. Buckley NA, Whyte IM, O’Connell D, Dawson AH. Oral or intravenous N-acetylcysteine: which is the treatment of choice for acetaminophen (paracetamol) poisoning? Journal of Toxicology – Clinical Toxicology 1999;37(6):759-767.

62. Buckley NA, Whyte IM, O’Connell D, Dawson AH. Activated charcoal reduces the need for N-acetylcysteine treatment after acetaminophen (paracetamol) overdose. Journal of Toxicology – Clinical Toxicology 1999;37(6):753-757.

2001-2010 63. Henry DA, Moxey AJ, Carless PA, O’Connell D, McClelland B, Henderson KM, Sly K,

Laupacis A, Fergusson D. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion (Cochrane Review). In: The Cochrane Library, Issue 1, 2001. Oxford: Update Software.

64. Kinlay JR, O’Connell DL, Kinlay S. Risk factors for mastitis in breastfeeding women: results of a prospective cohort study. ANZ J Pub Health 2001;25:115-20.

65. Robertson J, Fryer J, O’Connell D, Smith A, Henry D. Personal formularies – an index of prescribing quality? Eur J Clin Pharmacol 2001;57:333-41.

66. Robertson J, Fryer JL, O’Connell DL, Sprogis A, Henry DA. The impact of specialists on prescribing by general practitioners. Med J Aust 2001;175:407-11.

67. Henry DA, Moxey AJ, Carless PA, O’Connell D, McClelland B, Henderson KM, Sly K, Laupacis A, Fergusson D. Desmopressin for minimising perioperative allogeneic blood transfusion (Cochrane Review). In: The Cochrane Library, Issue 3, 2001. Oxford: Update Software.

68. Gillespie WJ, Avenell A, Henry DA, O’Connell DL, Robertson J. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis (Cochrane Review). In: The Cochrane Library, Issue 1, 2001. Oxford: Update Software.

69. Robertson J, Fryer JL, O’Connell DL, Smith AJ, Henry DA. Limitations of Health Insurance Commission (HIC) data for deriving prescribing indicators. Med J Aust 2002;176:419-424.

70. Henry DA, Carless PA, Moxey AJ, O’Connell D, Forgie MA, Wells PS, Fergusson D. Pre-operative autologous donation for minimising perioperative allogeneic blood transfusion (Cochrane Review). In: The Cochrane Library, Issue 4, 2002. Oxford: Update Software.

71. Wells G, Tugwell P, Shea B, Guyatt G, Peterson J, Zytaruk N, Robinson V, Henry D, O’Connell D, Cranney A. Meta-analyses of therapies for postmenopausal osteoporosis. V. Meta-analysis of the efficacy of hormone replacement therapy in treating and preventing osteoporosis in postmenopausal women. Endocr Rev 2002;23:529-539.

72. Pearson S-A, Rolfe I, Smith T, O’Connell D. Intern prescribing decisions: Few and far between. Education for Health 2002;15:315-325.

73. Hazell P, O’Connell D, Heathcote D, Henry D. Tricyclic drugs for depression in children and adolescents (Cochrane Review). In: The Cochrane Library, Issue 1, 2003. Oxford: Update Software.

74. Moxey A, O’Connell D, McGettigan P, Henry D. Describing treatment effects to patients: how they are expressed makes a difference. J Gen Intern Med 2003;18:948-959.

75. Carless PA, Rubens FD, Anthony DM, O’Connell D, Henry DA. Platelet-rich-plasmapheresis for minimising peri-operative allogeneic blood transfusion (Cochrane Review). In: The Cochrane Library 2003 Issue 2,. Oxford: Update Software.

76. Buckley NA, Chevalier S, Leditschke IA, O’Connell DL, Leitch J, Pond SM. The limited utility of electrocardiography variables used to predict arrhythmia in psychotropic drug overdose. Critical Care 2003;7:R101-R107.


77. Carless PA, Henry DA, Moxey AJ, O’Connell DL, Fergusson DA. Cell salvage for minimising perioperative allogeneic blood transfusion (Cochrane Review). In: The Cochrane Library 2003 Issue 4, Chichester, UK: John Wiley & Sons, Ltd.

78. Jong KE, Smith DP, Yu X, O’Connell D, Goldstein D, Armstrong B. Remoteness of residence and survival from cancer in New South Wales. MJA 2004;180:612-22.

79. The Grade Working Group (including O’Connell D). Grading quality of evidence and strength of recommendations. BMJ 2004;328:1490-94.

80. Yu XQ, O’Connell DL, Gibberd RW, Dickman PW, Armstrong BK. Estimating regional variation in cancer survival: a tool for improving cancer care. Cancer Causes and Control 2004;15:611-618.

81. Carless P, Moxey A, O’Connell D, Henry D. Autologous transfusion techniques: a systematic review of their efficacy. Transfusion Medicine 2004;14:123-144.

82. Yu XQ, O’Connell D, Forman D. Comparison of cancer survival in UK and Australia: rates are higher in Australia for three major sites. Br J Cancer 2004;91:1663-65.

83. Moxey A, O’Connell D, Deveridge S, Treloar C, Henry D. Involving older patients in decision making: a decision aid describing blood transfusion options for planned surgery. Abstracts and proceedings of ERA 2004. 3rd National Conference for Emerging Researchers in Ageing.

84. Atkins D, Eccles M, Flottorp S, Guyatt G, Henry D, Hill S, Liberati A, O’Connell D, et al. Systems for grading the quality of evidence and the strength of recommendations I: Critical appraisal of existing approaches. BioMed Central Health Services Research 2004;4:38. http://www.biomedcentral.com/1472-6963/4/38.

85. Moxey AJ, O’Connell DL, Treloar CJ, Han PYS, Henry DA. Blood transfusion and autologous donation: a survey of post-surgical patients, interest group members, and the public. Transfusion Medicine 2005;15:19-32.

86. Atkins D, Briss, PA, Eccles M, Flottorp S, Guyatt G, Harbor RT, Hill S, Jaeschke R, Liberati A, O’Connell D, et al. Systems for grading the quality of evidence and the strength of recommendations II: Pilot study of a new system. BioMed Central Health Services Research 2005;5:25.

87. Yu XQ, O’Connell DL, Gibberd RW, Armstrong BK. Area variation in survival from colorectal cancer New South Wales, Australia 1996-2001: population-based study. European J Cancer 2005;41:2715-21.

88. Avenell A, Gillespie WJ, Gillespie LD, O’Connell DL. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. The Cochrane Database of Systematic Reviews 2005, Issue 3. Art. No.: CD000227. DOI: 10.1002/14651858.CD000227.pub2. Substantial Update April 2005.

89. Yu XQ, O’Connell DL, Gibberd RW, Coates AS, Armstrong BK. Trends in survival and excess risk of death after a diagnosis of cancer in 1980 to 1996 in New South Wales Australia. Int J Cancer 2006;119:894-900.

90. Amin J, Dore GJ, O’Connell DL, Bartlett M, Tracey E, Kaldor JM, Law MG. Cancer incidence in people with hepatitis B or C infection: A large community-based linkage study. J Hepat 2006;45:197-203.

91. Malope BI, Pfeiffer RM, Mbisa G, Stein L, Ratshikhopha EM, O’Connell DL, Sitas F, MacPhail P, Whitby D. Transmission of Kaposi’s Sarcoma-associated Herpesvirus between mothers and children in a South African population. Journal of Acquired Immune Deficiency Syndromes 2007;44:351-355.

92. Young J, Leong D, Armstrong K, O’Connell D, et al. Concordance with national guidelines for colorectal cancer care – a population-based patterns of care study of 3095 patients. MJA 2007;186:292-295.

93. Sitas F, Urban M, Stein L, Beral V, Ruff P, Hale M, Patel M, O’Connell D, Yu XQ, Verzijden A, Marais D, Williamson A-L. The relationship between HPV-16 IgG serology and cancer of the cervix, oesophagus, oral cavity, anogenital region, and prostate in a black HIV-negative South African population: a case-control study. Infectious Agents and Cancer 2007;2:6.

http://www.biomedcentral.com/1472-6963/4/38


94. Chapuis PH, Chan C, Lin BPC, Armstrong K, Armstrong B, Spigelman A, O’Connell DL, Leong D, Dent OF. Pathology reporting of resected colorectal cancers in New South Wales in 2000. ANZ J Surg 2007;77;963-969.

95. Amin J, O’Connell DL, Bartlett M, Tracey E, Kaldor J, Law MG, Dore GJ. Liver cancer and hepatitis B and C in New South Wales 1990-2002: a linkage study. ANZ J Public Health 2007; 31(5):475-482.

96. Yu XQ, O’Connell DL, Gibberd RW, Abrahamowicz M, Armstrong BK. Misclassification of colorectal cancer stage and area variation in survival. Int J Cancer 2008;122:398-402.

97. Supramanian R, O’Connell D, Robotin M, Tracey E, Sitas F. Future cancer trends to be influenced by past and future migration. Letter. ANZ J Public Health 2008; 32:90-92.

98. Stein L, Urban MI, O’Connell D, Yu XQ, et al. The spectrum of human immunodeficiency virus-associated cancers in a South African black population: results from a case-control study, 1995-2004. Int J Cancer; 2008;122:2260–2265.

99. Vinod SK, O’Connell DL, Simonella L, Delaney GP, Boyer M, Peters M, Miller D, Supramaniam R, McCawley L, Armstrong B. Gaps in optimal care for lung cancer. J Thoracic Oncology 2008;3:871-879.

100. Hayen A, Smith DP, Patel MI, O’Connell DL. Patterns of surgical care for prostate cancer in NSW, 1993-2002: rural/urban and socioeconomic variation. ANZ J Public Health 2008;32:417-420.

101. Yu XQ, O’Connell DL, Gibberd RW, Armstrong BK. Assessing the impact of socio-economic status on cancer survival in New South Wales, Australia 1996-2001. Cancer Causes and Control. 2008;19;1383-1390.

102. Yu XQ, O’Connell DL. Estimating cancer prevalence using a simple SAS program. Australasian Epidemiologist 2008;15.2:17-18.

103. Woods LM, Rachet B, O’Connell D, Lawrence G, Tracey E, Willmore A, Coleman MP. Large differences in patterns of breast cancer survival between Australia and England: a comparative study using cancer registry data. Int J Cancer 2009;124:2391-2399.

104. Avenell A, Gillespie WJ, Gillespie LD, O'Connell D. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database of Systematic Reviews 2009, Issue 2. Art. No.: CD000227. DOI: 10.1002/14651858.CD000227.pub3. Substantial update.

105. Habib MR, Solomon MJ, Young JM, Armstrong BK, O’Connell D, Armstrong K. Evidence-based and clinical outcome scores to facilitate audit and feedback for colorectal cancer care. Dis Colon Rectum 2009;52:616-623.

106. Weber MF, Banks E, Smith DP, O’Connell D, Sitas F. Cancer screening among migrants in an Australian cohort; cross-sectional analyses from the 45 and Up Study. BMC Public Health 2009, 9:144. doi:10.1186/1471-2458-9-144

107. Yu XQ, O’Connell D, Armstrong B. Response to Barraclough et al. Letter to Editor. ANZ J Public Health 2009;33:95-96.

108. Vinod SK, Simonella L, Goldsbury D, Delaney GP, Armstrong B, O’Connell DL. Underutilization of radiotherapy for lung cancer in NSW, Australia. Cancer 2009;116:686-694.

109. Sitas F, O’Connell DL, Jamrozik K, Lopez A. Smoking questions on Australian death notification forms: adopting international best practice? MJA 2009;191:166-168.

110. Ringland CL, Arkenau H-T, O’Connell DL, Ward RL. Second primary colorectal cancers (SPCRCs): experiences from a large Australian Cancer Registry. Annals of Oncology 2009; doi: 10.1093/annonc/mdp288.

111. Simonella L, O’Connell DL, Vinod SK, Delaney GP, Boyer M, Esmaili N, Hensley M, Goldsbury D, Supramaniam R, Hui A, Armstrong B. No improvement in lung cancer care: The management of lung cancer in 1996 and 2002 in New South Wales. Internal Medicine Journal 2009;39:453-458.

112. Smith D, King MT, Egger S, Berry M, Stricker PD, Cozzi, P, Ward J, O’Connell DL, Armstrong BK. Quality of life three years after diagnosis of localised prostate cancer: A population-based study. BMJ 2009;339:b4817 doi:10.1136/bmj.b4817.


113. Woods LM, Rachet B, O’Connell D, Lawrence G, Tracey E, Willmore A, Coleman MP. Differences in breast cancer incidence in Australia and England by age, extent of disease and deprivation status: women diagnosed 1980-2002. Aust NZ J Public Health 2010;34:206-213.

114. Webster AC, Supramaniam R, O’Connell DL, Chapman JR, Craig JC. Validity of registry data: agreement between cancer records in an end stage kidney disease registry (voluntary reporting) and a cancer register (statutory reporting). Nephrology 2010;15:491-501.

115. Yu XQ, Chen W, O’Connell D. Improved survival of non-Hodgkin lymphoma patients in New South Wales, Australia. BMC Cancer 2010;10:231.

116. Sitas F, O’Connell DL, van Kemenade C, Short M, Zhao K. Breast cancer risk among female employees of the Australian Broadcasting Corporation in Australia. Med J Aust 2010;192:651-654.

2011-2020 117. Chambers SK, Pinnock C, Lepore SJ, Hughes S, O’Connell DL. A systematic review

of psychosocial interventions for men with prostate cancer and their partners. Patient Education and Counseling 2011:85:e75-e88.

118. Henry DA, Carless PA, Moxey AJ, O'Connell D, Stokes BJ, Fergusson DA, Ker K. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database of Systematic Reviews 2011, Issue 1. Art. No.: CD001886. DOI: 10.1002/14651858.CD001886.pub3. Substantial update.

119. Yu XQ, Smith DP, Clements MS, Patel MI, McHugh B, O’Connell DL. Projecting prevalence by stage of care for prostate cancer and estimating future health service needs: protocol for a modeling study. BMJ Open 2011;1:e000104 doi:10.1136/bmjopen-2011-000104.

120. Wang W, O’Connell D, Stuart K, Boyages J. Analysis of 10-year cause-specific mortality of patients with breast cancer treated in NSW in 1995. Journal of Medical Imaging and Radiation Oncology 2011;55:516-525.

121. Goldsbury DE, Smith DP, Armstrong BK, O’Connell DL. Using linked routinely collected health data to describe prostate cancer treatment in New South Wales, Australia: a validation study. BMC Health Services Research 2011;11:253 doi:10.1186/1472-6963-11-253.

122. Sitas F, Yu XQ, O’Connell D, Blizzard L, Otahal P, Newman L, Venn A. The relationship between basal and squamous cell skin cancer and smoking related cancers. BMC Research Notes 2011;4:556.

123. Kahn C, Simonella L, Sywak M, Boyages S, Ung O, O’Connell D. Pathways to the diagnosis of thyroid cancer in New South Wales: a population based cross-sectional study. Cancer Causes Control 2012;23:35-44 DOI 10.1007/s10552-011-9852-2.

124. Sitas F, Egger S, Urban MI, Taylor PR, Abnet CC, Boffetta P, O’Connell DL, et al. InterSCOPE study: Associations between esophageal squamous cell carcinoma and human papillomavirus serological markers. J Natl Cancer Inst 2012;104:147-158.

125. Urban M, Banks E, Egger S, Canfell K, O'Connell D, Beral V, Sitas F. Injectable and oral contraceptive use and cancers of the breast, cervix, ovary and endometrium in black South African women: case-control study. PLOS Medicine 2012. Accepted 20 December 2011.

126. Kahn C, Simonella L, Sywak M, Boyages S, Ung O, O’Connell D. Post-surgical pathology reporting of thyroid cancer in New South Wales, Australia. Thyroid. Accepted 1 February 2012.

Books and book chapters 1. O’Connell D, Glasziou P, Hill S (2000). How to use the evidence: assessment and

application of scientific evidence. Handbook series on preparing clinical practice


guidelines. NHMRC. Australia. http://www.nhmrc.gov.au/guidelines/publications/cp69 (accessed 11 November 2011)

2. O’Connell D, Glasziou P, Hill S, Sarunac J, Lowe J, Henry D. Results of clinical trials and systematic reviews: to whom do they apply? The Advanced Handbook of Methods in Evidence-based Healthcare. Ed: Stevens A, Abrams K, Brazier J, Fitzpatrick R, Lilford R. Sage Publications Ltd London 2001 pages 56-72.

3. Sewram V, Sitas F, O’Connell D, Myers H. Oesophageal cancer in South Africa. Accepted 23 June 2011.

Other publications 1980-1990 1. Dobson AJ, Gibberd RW, Sheehan T, Bennett SA, O’Connell DL, Firman DW,

Anderson T, Leeder SR and Landis JR (1984). Comparison of cardiovascular risk factors and mortality rates by city and occupation in Australia in 1980. University of Newcastle, N.S.W.

2. O’Connell DL, Lam P and Gibberd, RW (1986). Spatial variation in patterns of mortality in N.S.W. Report for Planning Division, N.S.W. Department of Health.

3. O’Connell DL, Lam P and Gibberd RW (1987). Mortality in New South Wales 1979-83: A study of spatial variation in cause specific mortality. University of Newcastle, N.S.W.

1991-2000 4. The University of Newcastle Osteoporosis Study Group. Henry D, Robertson J,

Gillespie W, O’Connell D (1995). Meta-analysis of Interventions for Prevention and Treatment of Post-menopausal Osteoporosis and Fracture. Report to Australian Institute of Health and Welfare.

5. Henry D, O’Connell D, Robertson J (1995). The value of bone densitometry in identifying women at risk of hip fracture and in guiding treatment decisions in postmenopausal women. Report to Medical Benefits Advisory Committee.

6. Henry D, O’Connell D (1996). General practitioners’ prescribing analysis project (GPPAP). Report to the General Practice Branch, Department of Human Services and Health, Canberra.

7. O’Connell D, Glasziou P, Hill S, Sarunac JN, Henry DA, Lowe J, Sackett D (1997). Assessing and increasing the generalisability of findings from randomised controlled trials (RCTs). Final report to UK National Health Service Health Technology Assessment Programme.

8. O’Connell D, Lowe, J, Candlish P, Wilkinson A, Silberberg J, Inder K (2000). Exercise rehabilitation in patients with congestive heart failure. A systematic review. Final report to AstraZeneca Pharmaceuticals, Australia.

9. O’Connell D, Fryer J, Hancock M, Foster M, Pekarsky B (2000). Maitland After Hours Primary Care Trial Local Evaluation Interim Report. Report to the Commonwealth Department of Health and Aged Care.

10. Hill S, Henderson K, O’Connell D, Fryer J, Henry D (2000). Integrated Care Project. First Evaluation Report. Report to the Pharmaceutical Alliance. The University of Newcastle.

2001-2010 11. Hill S, Henderson K, O’Connell D, Fryer J, Han P, Henry D (2001). Integrated Care

Project. Phase 1. Final Central Bayside Report. Report to the Pharmaceutical Alliance. The University of Newcastle.

12. Goumas C, O’Connell DL, Smith DP, Armstrong BK. Lung cancer in NSW in 1973 to 1998. Sydney: The Cancer Council NSW, 2001.

http://www.nhmrc.gov.au/guidelines/publications/cp69


13. Jong K, Smith DP, Yu XQ, Goumas C, O’Connell D, Armstrong BK. Remoteness and cancer incidence, mortality and survival in New South Wales 1992 to 1996. Sydney: The Cancer Council NSW, 2002.

14. Yu XQ, O’Connell D, Gibberd R, Smith D, Armstrong B. Cancer survival, incidence and mortality by Area Health Service in NSW 1994 to 2000. Sydney: The Cancer Council NSW, 2003.

15. Armstrong K, O’Connell DL, Leong D, Spigelman AD, Armstrong BK. The New South Wales colorectal cancer care survey – Part 1 surgical management. The Cancer Council NSW, 2004.

16. Boyages J, Jayasinghe U, Heard G, O’Connell D, Taylor R. The management of breast cancer in New South Wales in 1995. Breast Cancer Institute NSW, 2005.

17. Armstrong K, O’Connell DL, Leong D, Yu XQ, Spigelman AD, Armstrong BK. The New South Wales colorectal cancer care survey – Part 2 chemotherapy management. The Cancer Council NSW, 2005.

18. Yu XQ, O’Connell DL, Armstrong BK, Gibberd RW. Trends in cancer survival in NSW 1980 to 1996. Sydney: The Cancer Council NSW, 2006.

19. Supramaniam R, O’Connell DL, Tracey EA, Sitas F. Cancer incidence in New South Wales migrants 1991 to 2001. Sydney: The Cancer Council NSW, 2006.

20. Bois J, Clements M, Yu XQ, Supramaniam R, Smith DP, Bovaird S, O’Connell DL. Cancer maps for New South Wales 1998 to 2002. Sydney: The Cancer Council NSW, 2007.

21. Armstrong K, Kneebone A, O’Connell DL, Leong D, Yu XQ, Spigelman AD, Armstrong BK. The New South Wales Colorectal Cancer Care Survey 2000 Part 3. Radiotherapy management for rectal cancer. The Cancer Council NSW, 2007.

22. Newman C, Treloar C, Brener L, Ellard J, O’Connell D, Butow P, Supramaniam R, Dillon A. Aboriginal Patterns of Cancer Care: a five-year study in New South Wales. Aboriginal & Islander Health Worker Journal 2008;32(3): 6-7.

23. Clements M, Egger S, O’Connell D. Incidence and prevalence estimation for metastatic breast cancer in Australia. Commissioned report for the National Breast and Ovarian Cancer Centre Sydney, 2008.

24. Khalaj B, Clements M, Roder D, Tracey E, Chen S, O’Connell D. Projections of cancer incidence in New South Wales: a comparison of different methods. Sydney: Cancer Institute NSW, June 2008.

25. Sitas F, O’Connell D. The ABC Women’s Health Study. Sydney: The Cancer Council NSW, August 2009.

26. O’Connell D, Armstrong K, Simonella L. Developing and assessing treatment algorithms for the management of lung cancer in NSW. Cancer Institute NSW NSWOG – Lung Group. September 2010. http://www.cancerinstitute.org.au/supporting-best-practice/treatments-and-

protocols/lung-cancer-treatment-algorithms

Submitted papers 1. Clements MS, Roder DM, Yu XQ, Egger S, O’Connell DL. Estimating prevalence of

distant metastatic breast cancer: a means of filling a data gap. 2. Carmichael LK, Smith DP, Gattellari M, Chambers SK, Pinnock CB, Slevin TJ, Ward

JE, O’Connell DL. Prostate-specific antigen testing awareness and participation in New South Wales, Australia: demographic, lifestyle and health-related factors.

3. Carmichael LK, Goldsbury DE, Smith DP, Gattellari M, Chambers SK, Slevin TJ, O’Connell DL. Men having PSA tests after the age of 75: who are they?

6. Armstrong K, Young JM, Solomon M, Armstrong BK, Kneebone AB, Ackland SP, Spigelman AD, Leong DC, O’Connell DL. Concordance with national management guidelines and longer term survival from colorectal cancer: a population-based study.

7. Yu XQ, Baade P, O’Connell D. Conditional survival of cancer patients in New South Wales: stage-specific analyses of 11 major cancers.

http://www.cancerinstitute.org.au/supporting-best-practice/treatments-and-protocols/lung-cancer-treatment-algorithms

http://www.cancerinstitute.org.au/supporting-best-practice/treatments-and-protocols/lung-cancer-treatment-algorithms


8. Chambers SK, Dunn J, Occhipinti S, Hughes S, Baade P, Sinclair S, Aitken J, Youl P, O’Connell DL. A systematic review of the impact of stigma and nihilism on lung cancer outcomes.

9. Goldsbury D, Harris M, Pascoe S, Olver I, Barton M, Spigelman A, O’Connell D. Sociodemographic and other patient characteristics associated with time between colonoscopy and surgery and choice of treatment centre for colorectal cancer.

Proffered presentations and posters 1980-1990 1. O’Connell DL. A GLIM view of smoking. Symposium on Medical Statistics.

Macquarie University, August, 1981. 2. O’Connell DL, Davis CE, Hazard C, Irving S and Rubenstein C. Classification of

Endpoints in the Lipid Research Clinics (LRC) Coronary Primary Prevention Trial (CPPT). Sixth Annual Meeting of the Society for Clinical Trials. New Orleans, May, 1985.

3. O’Connell DL. Methods of analysis used in a twin study of the genetic and environmental effects on lipid levels. It Runs in the Family III – Statistical methods for linkage, pedigree and twin analyses. University of Melbourne, March, 1989.

4. O’Connell DL, Halliday J, Heller RF, Roberts DC. Genetic and environmental effects on response of blood cholesterol to diet change. Presentation for the Ralph Reader Prize, 38th Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand. Hobart, April, 1990.

5. O’Connell DL, Halliday J, Heller RF, Roberts DC. Genetic and environmental effects on response of blood cholesterol to diet change. 12th Scientific Meeting of the International Epidemiological Association. Los Angeles, August, 1990.

1991-2000 6. O’Connell DL, Heller RF, Halliday J. Hormones, hysterectomy and the risk of acute

myocardial infarction in women. 13th Scientific Meeting of the International Epidemiological Association. Sydney, September, 1993.

7. O’Connell DL, Henry D, Robertson J, Gillespie W, et al. Oestrogens in the prevention of post-menopausal osteoporosis and fracture: a meta-analysis. 13th Scientific Meeting of the International Epidemiological Association. Sydney, September, 1993.

8. Gillespie WJ, Henry DA, O’Connell DL, Robertson J, Lau EM. Vitamin D analogues in the prevention of axial and appendicular fractures: report of a meta-analysis. Poster. 3rd Annual Cochrane Colloquium. Oslo, 4-8 October 1995.

9. O’Connell D, Robertson J, Henry D, Gillespie W. Estrogens and osteoporosis: investigators concerned with technology rather than clinical science. Poster. 3rd Annual Cochrane Colloquium. Oslo, 4-8 October 1995.

10. O’Connell D, Robertson J, Henry D, Gillespie W. Estrogens and osteoporosis: quality of observational studies. Poster. 3rd Annual Cochrane Colloquium. Oslo, 4-8 October 1995.

11. Robertson J, McGowan J, Shea B, O’Connell D, Henry D, Mears S, Wells G, Tugwell P. Estrogens and osteoporosis: a comparison of search strategies for RCTs using a broad labour-intensive search strategy, and Cochrane searching algorithms. Poster. 3rd Annual Cochrane Colloquium. Oslo, 4-8 October 1995.

12. Hazell PL, O’Connell D, et al. Handling multiple outcome measures. Poster. 3rd Annual Cochrane Colloquium. Oslo, 4-8 October 1995.

13. Henry D, O’Connell D. Patterns and costs of prescribing – a divisional perspective. General Practice Evaluation Conference. Sydney, 24-25 November 1995.

14. O’Connell D, Henry D. Factors related to variability in prescribing by Australian general practitioners. 29th Annual Meeting of ASCEPT. Adelaide, 3-6 December 1995.


15. Robertson J, O’Connell D, Dobbins T, Henry D. Variability in prescribing between and within divisions. Is it important? General Practice Evaluation Conference. Sydney, 1-2 August 1996.

16. O’Connell D, Henry D, Glasziou P, et al. Results from RCTs and systematic reviews: to whom do they apply? 4th International Cochrane Colloquium. Adelaide, 20-24 October 1996.

17. O’Connell D, Henry D, Glasziou P, et al. Results from RCTs and systematic reviews: to whom do they apply? 13th International Meeting of the International Society of Technology Assessment in Health Care. Barcelona, 25-28 May 1997.

18. O’Connell D, Silberberg J. Usefulness and limitations of meta-analysis for pharmaco-economic evaluation. International policies in health economics: state of play and future directions for pharmaceuticals. Drug Information Association Workshop. Cairns, September 1997.

19. O’Connell D, Doran E, Hill S, Henry D. Approaches to applicability in the recent literature. 6th International Cochrane Colloquium. Baltimore, 22-26 October 1998.

20. O’Connell DL, Hill SR, Henry D, McGettigan P. Health technology assessment: an overview of methods for assessing, applying and presenting the evidence. Poster. 15th Annual Meeting of the International Society of Technology Assessment in Health Care. Edinburgh, 20-23 June 1999.

2001-2010 21. Moxey A, O’Connell D, McGettigan P, Henry D. The effects of information framing on

patients’ treatment decisions. Poster. 9th Cochrane Colloquium Lyon, 9-13 October 2001.

22. Henry D, Moxey A, O’Connell D. Agreement between randomized and non-randomized studies – the effects of bias and confounding. Poster. 9th Cochrane Colloquium Lyon, 9-13 October 2001. Awarded the Thomas C Chalmers Excellence Award for best presentation.

23. Yu XQ, O’Connell D, Smith D. Estimating regional variation in cancer survival: use of Empirical Bayes methods. Clinical Oncological Society of Australia 30th Annual Scientific Meeting Perth 25-28 November 2003.

24. King D, O’Connell DL, King K, McCawley L. Ascertaining and recruiting patients with lung cancer for research through a population-based cancer registry. Clinical Oncological Society of Australia 31st Annual Scientific Meeting Canberra 24-26 November 2004.

25. Clements M, O’Connell D. Innovative approaches to cancer rate modelling. Clinical Oncological Society of Australia 31st Annual Scientific Meeting Canberra 24-26 November 2004.

26. Supramaniam R, Tracey E, O’Connell D, Sitas F. Cancer incidence by country of birth in New South Wales 1991-2001. Clinical Oncological Society of Australia 31st Annual Scientific Meeting Canberra 24-26 November 2004.

27. Yu XQ, O’Connell DL, Gibberd RW, Coates AS, Armstrong BK. Trends in survival from major cancers in NSW 1980-1996. Poster. Clinical Oncological Society of Australia 31st Annual Scientific Meeting Canberra 24-26 November 2004.

28. Vinod SK, O’Connell DL, King DR, Simonella L, Supramaniam R, McCawley L, Armstrong BK. Patterns of care for lung cancer in New South Wales, Australia: preliminary results. Poster. 11th World Conference on Lung Cancer (IASLC) Barcelona, Spain 3 – 6 July 2005.

29. Delaney G, O’Connell D, Simonella L, et al. Patterns of care for lung cancer in NSW. RANZCR 56th Annual Scientific Meeting Sydney 6-9 October 2005.

30. Yu XQ, O’Connell DL, Gibberd RW, Armstrong BK. Assessing the impact of measurement errors of spread of cancer on estimates of regional variation in survival from colorectal cancer. Australasian Epidemiological Association Annual Conference Newcastle 6-8 October 2005.


31. Yu XQ, O’Connell DL, Gibberd RW, Armstrong BK. Accuracy of disease stage for colorectal cancer in a population-based cancer registry, New South Wales, Australia. Clinical Oncological Society of Australia 32nd Annual Scientific Meeting Brisbane 16-18 November 2005.

32. Supramaniam R, O’Connell D, Tracey E, Sitas F. Differences in cancer incidence by country of birth in New South Wales: healthy migrants, ascertainment bias or salmon swimming upstream? Clinical Oncological Society of Australia 32nd Annual Scientific Meeting Brisbane 16-18 November 2005.

33. Simonella L, O’Connell DL, King DR, Supramaniam R, McCawley L, Armstrong BK. Lung cancer management in New South Wales: diagnosis and treatment. Poster. Clinical Oncological Society of Australia 32nd Annual Scientific Meeting Brisbane 16-18 November 2005.

34. O’Connell D, King D, Simonella L, Supramaniam R, McCawley L, Armstrong BK. Lung cancer management in New South Wales: results for key practice indicators. Poster. Clinical Oncological Society of Australia 32nd Annual Scientific Meeting Brisbane 16-18 November 2005.

35. Simonella LM, O’Connell DL, Vinod S et al. Are we up to scratch? Comparisons in lung cancer management in New South Wales between 1996 and 2002. Oral presentation. Clinical Oncological Society of Australia 33rd Annual Scientific Meeting Melbourne 29 November-1 December 2006.

36. Robotin M, Supramaniam R, Sitas F, O’Connell D, Penman AG. Reducing the incidence of stomach cancer – should we screen populations at higher risk? Oral presentation. Clinical Oncological Society of Australia 33rd Annual Scientific Meeting Melbourne 29 November-1 December 2006.

37. Robotin MC, Supramaniam R, Sitas F, O’Connell D, Penman AG. Hepatocellular cancer and hepatitis B infection: is a public health response required? Oral presentation. Clinical Oncological Society of Australia 33rd Annual Scientific Meeting Melbourne 29 November-1 December 2006.

38. Yu X, O’Connell DL, Gibberd RW, Armstrong BK. Assessing the relation of socio-economic status on cancer survival in New South Wales, 2001. Oral presentation. Clinical Oncological Society of Australia 33rd Annual Scientific Meeting Melbourne 29 November-1 December 2006.

39. Picker J, Clements M, Yu X, Supramaniam R, Smith DP, Bovaird S, O’Connell DL. Geographic variation in cancer incidence and mortality in NSW 1998 to 2002. Poster. Clinical Oncological Society of Australia 33rd Annual Scientific Meeting Melbourne 29 November-1 December 2006.

40. Sitas F, Canfell K, O’Connell DL. The NSW Clear Study: Design and setting. Poster. Clinical Oncological Society of Australia 33rd Annual Scientific Meeting Melbourne 29 November-1 December 2006.

41. Robotin MC, Britt H, Knox D, O’Connell D, Penman AG. The changing face of skin cancer management in Australian general practice. Poster. Clinical Oncological Society of Australia 33rd Annual Scientific Meeting Melbourne 29 November-1 December 2006.

42. O’Connell D, Simonella L, McCawley L, Miller D, Armstrong BK. The lung cancer patient’s journey in NSW. Poster. Clinical Oncological Society of Australia 33rd Annual Scientific Meeting Melbourne 29 November-1 December 2006.

43. O’Connell DL, Armstrong K, Leong D, Armstrong BK. Patient outcomes two years after diagnosis of colorectal cancer in NSW. Poster. Clinical Oncological Society of Australia 33rd Annual Scientific Meeting Melbourne 29 November-1 December 2006.

44. O’Connell DL, Carmichael LK, Smith DP, et al. Factors related to the awareness of, and participation in, Prostate-Specific Antigen testing in NSW. Oral presentation. Clinical Oncological Society of Australia 34th Annual Scientific Meeting Adelaide 14-16 November 2007.


45. Goldsbury D, O’Connell D. Using linked routinely-collected data to examine patterns of cancer care in NSW from 1993 to 2002. Poster. Clinical Oncological Society of Australia 34th Annual Scientific Meeting Adelaide 14-16 November 2007.

46. Supramaniam R, O’Connell D. Cancer care for Aboriginal people in NSW 1994 to 2002. How does it compare? Oral presentation. Clinical Oncological Society of Australia 34th Annual Scientific Meeting Adelaide 14-16 November 2007.

47. Supramaniam R, O’Connell D. Cancer care for Aboriginal people in New South Wales: How does it compare? Oral presentation. Population Health Congress Brisbane 7-9 July 2008.

48. Carmichael L, O’Connell D, on behalf of the Men’s Health Study Team. Demographic factors related to the awareness of, and participation in, PSA testing in NSW, Australia. Population Health Congress Brisbane 7-9 July 2008.

49. Weber MF, O’Connell D, Banks E, Smith DP, Sitas F. Cancer screening among migrants in the 45 and Up Study cohort in New South Wales. Oral presentation. Sydney Cancer Conference Sydney 25-26 July 2008.

50. Carmichael LK, O’Connell DL, Smith DP, Gattellari M, Steginga S, Pinnock C, Rodger J, Ward J, Slevin T. Demographic and lifestyle factors related to the awareness of, and participation in, prostate specific antigen testing in New South Wales. Poster. Sydney Cancer Conference Sydney 25-26 July 2008.

51. Ringland CL, Ward RL, O’Connell DL. Risk of second primary colorectal cancers in New South Wales. Poster. Sydney Cancer Conference Sydney 25-26 July 2008.

52. Carmichael LK, O’Connell DL, Smith DP, et al. Demographic factors related to the awareness of, and participation in, prostate specific antigen testing in New South Wales, Australia. Oral presentation. COSA – IACR 2008 Joint Scientific Meeting. Sydney 18-20 November 2008.

53. Yu XQ, Chen W, O’Connell DL. Trend in survival from non-Hodgkin lymphoma 1990-2004 in New South Wales, Australia. Oral presentation. COSA – IACR 2008 Joint Scientific Meeting Sydney 18-20 November 2008.

54. Chambers S, Carmichael LK, Pinnock C, O’Connell DL. Family history of prostate cancer and PSA testing behaviour. Poster. COSA – IACR 2008 Joint Scientific Meeting Sydney 18-20 November 2008.

55. Sitas F, Canfell K, Delgado A, Christian K, Burcham JL, O’Connell DL, et al. A novel recruitment method in case-control studies of cancer: initial experience with the NSW CLEAR study. Poster. COSA – IACR 2008 Joint Scientific Meeting Sydney 18-20 November 2008.

56. Goldsbury DE, O’Connell DL, Smith DP, Simonella L. The validity of linked routinely collected data for describing and monitoring cancer care. Poster. Finalist in “Best of the Best”. COSA – IACR 2008 Joint Scientific Meeting Sydney 18-20 November 2008.

57. Simonella L, O’Connell DL, Goldsbury DE. Does treatment according to guidelines improve lung cancer survival. Poster. COSA – IACR 2008 Joint Scientific Meeting Sydney 18-20 November 2008.

58. Simonella L, O’Connell DL, Goldsbury DE. Reasons for not meeting lung cancer treatment guidelines in New South Wales, Australia. Poster. COSA – IACR 2008 Joint Scientific Meeting Sydney 18-20 November 2008.

59. Vinod SK, Simonella L, Goldsbury D, Delaney GP, Armstrong BK, O’Connell DL. Underutilisation of Radiotherapy for Lung Cancer in New South Wales, Australia. Poster presentation at World Lung Cancer Conference. San Francisco, USA, 2009.

60. Kahn C, O’Connell DL, Simonella L, Sywak M. Pathways to the diagnosis of thyroid cancer in New South Wales. Poster. COSA - 36th Annual Scientific Meeting Gold Coast 17-19 November 2009.

61. Rodger J, Supramaniam R, O’Connell DL, Saunders V. Challenges in conducting the Aboriginal Patterns of Cancer Care (APOCC) project. Poster. COSA - 36th Annual Scientific Meeting Gold Coast 17-19 November 2009.

62. Sitas F, Yu XQ, O’Connell DL, Blizzard L, Otahal P, Newman L, Venn A. Higher risk of smoking related cancers in people with non-melanoma skin cancer: opportunities for


prevention. Poster. COSA - 36th Annual Scientific Meeting Gold Coast 17-19 November 2009.

63. Supramaniam R, O’Connell DL. Beyond access: is Aboriginality a risk factor for survival after breast cancer? Poster. COSA - 36th Annual Scientific Meeting Gold Coast 17-19 November 2009.

64. Sitas F, O’Connell DL, Burcham J, Van Kemenade C. Breast cancer risk among Australian Broadcasting Corporation female employees in Australia. Winner of Best of the Best Oral Presentations. COSA – 36th Annual Scientific Meeting Gold Coast 17-19 November 2009.

65. Goldsbury DE, O’Connell DL. Survival after cancer surgery: is there a difference between public and private hospitals? Finalist in Best of the Best Oral Presentations. COSA - 36th Annual Scientific Meeting Gold Coast 17-19 November 2009.

66. Simonella L, Goldsbury D, Egger S, Vinod S, Delaney G, Boyer M, Peters M, Armstrong B, O’Connell D. Providing optimal evidence based treatment for non-small cell lung cancer improves survival. Oral presentation. Sydney Cancer Conference 14-16 July 2010.

67. Kahn C, O’Connell D, Simonella L, Sywak M. Pathways to diagnosis of thyroid cancer in New South Wales. Oral presentation. Sydney Cancer Conference 14-16 July 2010.

68. Supramaniam R, O’Connell D. Beyond access: is Aboriginality a risk factor for survival after breast cancer? Oral presentation. Sydney Cancer Conference 14-16 July 2010.

69. Sitas F, O’Connell D, van Kemenade C, Short M, Zhao K. A follow up of a breast cancer cluster among Australian Broadcasting Corporation female employees in Australia. Oral presentation. Sydney Cancer Conference 14-16 July 2010.

70. Rodger J, Supramaniam R, O’Connell D, Saunders V. Challenges in conducting the Aboriginal Patterns of Cancer Care (APOCC) Project. Poster. Sydney Cancer Conference 14-16 July 2010.

71. Goldsbury DE, Smith DP, Armstrong BK, O'Connell DL. Accuracy of hospital records and Medicare claims data for monitoring prostate cancer care. Poster. Clinical Oncological Society of Australia Meeting. Melbourne, Australia, 2010.

72. O'Connell DL, Carmichael LK, Smith DP, Gattellari M, Chambers S, Pinnock CP, Slevin T, Ward J. Prostate cancer and PSA testing. How much do men think they know? What do they know? Poster. Clinical Oncological Society of Australia. Melbourne, Australia, 2010.

73. Rodger J, Supramaniam R, Saunders V, O'Connell DL. Pathways to the Diagnosis of Cancer for Aboriginal People in NSW. Poster. Clinical Oncological Society of Australia. Melbourne, Australia, 2010.

74. Supramaniam R, O'Connell DL, Rodger J, Saunders V, Dennis J. Differences in socioeconomic status, spread of disease, rural residence and access to surgery do not explain lower survival from breast cancer for Aboriginal women. Best of the best poster. Clinical Oncological Society of Australia. Melbourne, Australia, 2010.

75. Smith DP, Egger S, O’Connell DL, et al. Sexual function five years after diagnosis of localized prostate cancer: results from the New South Wales (NSW) Prostate Cancer Care and Outcomes Study. Oral presentation. Clinical Oncological Society of Australia. Melbourne, Australia, 2010.

76. O’Connell DL, Armstrong K, Vinod S, Simonella L, Thomas R, Peters M. Algorithms for the management of lung cancer in New South Wales. Poster. Clinical Oncological Society of Australia. Melbourne, Australia, 2010.

77. Yu XQ, Clements M, O’Connell DL. Projecting prevalence by stage of care for colon cancer and estimating future health service needs. Poster. Clinical Oncological Society of Australia. Melbourne, Australia, 2010.

2011- 78. Supramaniam R, O’Connell D. Lower breast cancer survival for Aboriginal women in

NSW was not explained by demographic, disease or surgery factors. Oral


presentation. 3rd CRIAH Aboriginal Health Research Conference. Sydney, Australia, 5-6 May 2011.

79. Yu XQ, Clements M, O’Connell D. Estimating fraction cured from cancer: which statistical package to use? Poster. IEA World Congress of Epidemiology. Edinburgh, UK, 7-11 August 2011.

80. Supramaniam R, Tang A, O’Connell D. Epidemiology and Indigenous health policy: rising to the challenge. Poster. IEA World Congress of Epidemiology. Edinburgh, UK, 7-11 August 2011.

81. YU XQ, Clements M, O’Connell D. Projecting prevalence by stage of care for colon cancer and estimating future health service needs in New South Wales Australia. Poster. IEA World Congress of Epidemiology. Edinburgh, UK, 7-11 August 2011.

82. O’Connell D, Kahn C, Simonella L, Sywak M, Boyages S, Ung O. Pathways to diagnosis do not explain all of the increase in thyroid cancer: results of a population based cross-sectional study. Poster. IEA World Congress of Epidemiology. Edinburgh, UK, 7-11 August 2011.

83. O’Connell D, Carmichael L, Smith D, Gattellari M, Chambers S, Pinnock C, Slevin T, Ward J. Prostate-specific antigen testing awareness and participation in New South Wales, Australia: demographic, lifestyle and health-related factors. Poster. IEA World Congress of Epidemiology. Edinburgh, UK, 7-11 August 2011.

84. Supramaniam R, O’Connell D. Differences in socioeconomic status, spread of disease, rural residence and access to surgery do not explain lower survival from breast cancer for Aboriginal women. Poster. IEA World Congress of Epidemiology. Edinburgh, UK, 7-11 August 2011.

85. O’Connell D, Kahn C, Simonella L, Sywak M, Boyages S, Ung O. Post-surgical pathology reporting of thyroid cancer in NSW. Poster. COSA – 38TH Annual Scientific Meeting Perth, 17th – 19th November 2011.

86. Supramaniam R, Rowstorne P, Rodger J, Dillon A, Butow P, Saunders V, O’Connell DL. Developing a questionnaire to explore the pathways to diagnosis of cancer for Aboriginal people in NSW – The Aboriginal Patterns of Cancer Care Study (APOCC). Poster. COSA – 38TH Annual Scientific Meeting Perth, 17th – 19th November 2011.

87. Supramaniam R, Gibberd A, O’Connell D. Lung cancer treatment and survival for Aboriginal people in NSW – The Aboriginal Patterns of Cancer Care Study (APOCC). Poster. COSA – 38TH Annual Scientific Meeting Perth, 17th – 19th November 2011.

88. Goldsbury DE, O’Connell DL. Pancreatic cancer surgery and survival in NSW. A population-based observational study using linked data and propensity scoring. Poster. COSA – 38TH Annual Scientific Meeting Perth, 17th – 19th November 2011.

89. Luo Q, Yu XQ, Smith DP, O’Connell DL. Characteristics of men with unknown spread of prostate cancer at diagnosis: Analysis of NSW Central Cancer Registry data. Poster. COSA – 38TH Annual Scientific Meeting Perth, 17th – 19th November 2011.

90. Carmichael LK, Goldsbury DE, Smith DP, Gattellari M, Chambers S, Slevin TJ, O’Connell D L. Who are the men aged over 75 who are having PSA tests? Nominated for Best of the Best Oral Presentation – Urology. COSA – 38TH Annual Scientific Meeting Perth, 17th – 19th November 2011.

91. Smith D, Egger S, O’Connell DL, King MT, Berry MP, Stricker PD, Cozzi P, Armstrong BK. Patient reported quality of life in men diagnosed with advanced prostate cancer: 5 year results of the NSW Prostate Cancer Care and Outcomes Study. Nominated for Best of the Best Oral Presentation – Urology. COSA – 38TH Annual Scientific Meeting Perth, 17th – 19th November 2011.

92. Yu X, Luo Q, Smith DP, Clements MS, O’Connell DL. Challenges in projecting prevalence for prostate cancer: issues and options. Nominated for Best of the Best Oral Presentation – Epidemiology. COSA – 38TH Annual Scientific Meeting Perth, 17th – 19th November 2011.

93. Pascoe SW, Harris MF, O’Connell DL, Veitch C, Beilby JJ, Spigelman AD, Goldsbury D, Barton MB, Olver I, Crossland L, Stubbs J. The colorectal cancer referral pathways project: findings from record linkage, audit of referral letters and focus groups.


Nominated for Best of the Best Oral Presentation – Primary Care. COSA – 38TH Annual Scientific Meeting Perth, 17th – 19th November 2011.

Invited presentations and lectures 1980-1989 1. O’Connell DL. Statistical techniques for the analysis of twin studies. Seminar

presented to Department of Statistics, University of Newcastle, November, 1988. 1990-2000 2. O’Connell DL, Halliday J. Genetic and environmental effects on the response of blood

cholesterol to diet change: a twin study. Seminar presented to Department of Statistics, University of Newcastle. March, 1990.

3. O’Connell DL. Invited speaker and tutor at Meta-analysis of Clinical Trials Workshop at Newcastle 2-3 September, 1990.

4. O’Connell DL. Sample Size Determination. Invited speaker: King George’s Medical College, Lucknow, India, April 1990 Faculty of Medicine and Department of Biostatistics, Christian Medical College, Vellore India, April 1991 West China University of Medical Sciences, Chengdu, People’s Republic of China, May 1992.

5. O’Connell DL. Introduction to Meta-analysis. Invited speaker. Continuing medical education session. Indiaclen meeting Delhi, 17-19 October, 1992.

6. O’Connell DL. Invited speaker at workshop for Rheumatology Registrars organised by the Australian Rheumatism Association, NSW Group at Newcastle 24-25 October, 1992.

7. O’Connell DL, Henry D, Robertson J, Gillespie W, et al. Oestrogens in the prevention of post-menopausal osteoporosis and fracture: a meta-analysis. Invited talk at Australian Medical Association Women and Medicine Annual Seminar. Canberra, February, 1994.

8. O’Connell DL. Assessment of intra- and inter- observer agreement – dos and don’ts. Seminar presented to the Musculoskeletal Research Group, Newcastle, March 1994.

9. O’Connell DL. Methods of pooling in meta-analysis. Lecture given to pharmaco-epidemiology fellows, Newcastle, July 1994.

10. O’Connell DL. Statistical Considerations in Designing GP-Based Studies. Invited speaker. Workshop on Research Involving Patients of General Practitioners. Newcastle, 6 May 1995.

11. O’Connell D, Henry D. GP prescribing analysis project. Summary of main findings. Presentation to PHARM Committee. Canberra, 10 November 1995.

12. O’Connell DL. The use of cumulative meta-analysis. Journal Club at Centre for Clinical Epidemiology and Biostatistics, Newcastle, July 1996.

13. O’Connell DL. Results from RCTs and systematic reviews: to whom do they apply? Seminar presented at Discipline of Clinical Pharmacology September 1996, Centre for Clinical Epidemiology and Biostatistics November 1996, Grand Rounds John Hunter Hospital September 1998.

14. O’Connell DL. Methods for systematic reviews and meta-analysis. Seminar presented at Hunter Centre for Health Advancement July 1998.

15. O’Connell D. Applying the evidence to the individual. Invited Discussant. Evidence-based Health Advice Workshop. The Menzies Foundation. Melbourne, 3-4 November 1998.

16. O’Connell D. Taking the quality of evidence into account when interpreting the evidence. Invited Speaker, International Clinical Trials Symposium. Improving health care in the new millennium. Sydney, 15-17 September 1999.

2001-2010


17. Yu XQ, O’Connell D, Smith D. Estimating regional variation in cancer survival: use of Empirical Bayes methods. Invited presentation. EpiSig meeting. NSW Health Department. June 2003.

18. O’Connell D, Yu XQ, Smith D. Estimating regional variation in cancer survival: implications for cancer care. Invited Speaker. Clinical Oncological Society of Australia 30th Annual Scientific Meeting Perth 25-28 November 2003.

19. O’Connell D. Study quality is everything! Invited speaker. IUPHAR 8th World Congress on Clinical Pharmacology and Therapeutics Brisbane 1-6 August 2004.

20. O’Connell D, King D, King K, McCawley L, Armstrong BK. Patterns of care for lung cancer in NSW: preliminary results. Invited Speaker. Clinical Oncological Society of Australia 31st Annual Scientific Meeting Canberra 24-26 November 2004.

21. O’Connell D. Cancer Screening. Invited Speaker. Consumer Research Training. Cancer Council, NSW 2005.

22. O’Connell D, Simonella L. Patterns of care for lung cancer in NSW. Management of NSCLC Stages I & II. Invited Presentation. Inaugural Australian Lung Cancer Conference 2006: Multidisciplinary Care Cairns 30 June-2 July 2006.

23. O’Connell D, Simonella L. Patterns of care for lung cancer in NSW. Management of NSCLC Stages III & IV. Invited Presentation. Inaugural Australian Lung Cancer Conference 2006: Multidisciplinary Care Cairns 30 June-2 July 2006.

24. O’Connell D, Simonella L. The journey of lung cancer patients in NSW. Invited Presentation. Inaugural Australian Lung Cancer Conference 2006: Multidisciplinary Care Cairns 30 June-2 July 2006.

25. O’Connell DL. Describing patterns of cancer care using administrative data sets. Invited Speaker. Workshop on Using CheReL for Research organized by the Sax Institute. Sydney 8 December 2006.


27. O’Connell D, Goldsbury D. Analysis of large population-based datasets to describe patterns of cancer care. Invited speaker EpiSIG NSW Department of Health July 2007.

28. O’Connell D. Cancer epidemiology research and patterns of care studies at The Cancer Council NSW. Invited Seminar, Children’s Cancer Institute Australia, 10 September 2007.


30. O’Connell D, Simonella L, Miller D, Supramaniam R, McCawley L, Armstrong B. Patterns of care for lung cancer in NSW. Invited speaker. Lung Cancer Clinical Forum. NSW Oncology Group Lung. Sydney, 2 November 2007.

31. O’Connell D, Supramaniam R, Kahn C. Thyroid cancer incidence in NSW: what might explain the increase? Invited Speaker. Clinical Oncological Society of Australia 34th Annual Scientific Meeting Adelaide 14-16 November 2007.

32. O’Connell D, Smith D, Hughes S, et al. Development of clinical practice guidelines for advanced prostate cancer. Invited Speaker. Clinical Oncological Society of Australia 34th Annual Scientific Meeting Adelaide 14-16 November 2007.

33. O’Connell D. Patterns of care – assessing the appropriateness and quality of cancer care. Invited speaker. Cancer Australia National Cancer Data Strategy Advisory Group Sydney 12 March 2008.

34. O’Connell D. Using linked data to look at patterns of cancer care. Invited speaker. Making the most of the CheReL: a burgeoning resource for health research and policy in ACT. Canberra 21 August 2008.

35. O’Connell D. Epidemiological Research. Invited speaker. Consumer Research Training. Cancer Council NSW, 5 September 2008.

36. O’Connell D. Patterns of cancer care studies in NSW. Invited Speaker. 5th Annual CE Workshop. Charles Sturt University. Wagga Wagga 1-2 November 2008.


37. O’Connell D, Goldsbury D. Using linked data for assessing patterns of cancer care. Linking cancer and other health data – challenges and issues – a global view – a record linkage workshop. Sydney 17 November 2008.

38. Chambers SK, Pinnock C, O’Connell DL, Hughes S, Jones L, Smith D. Supportive care for advanced prostate cancer: update and discussion of clinical practice and consumer guidelines. Invited presentation. COSA – IACR 2008 Joint Scientific Meeting Sydney 18-20 November 2008.

39. Supramaniam R, O’Connell DL, Ellard J, Newman CE, Brener L, Treloar C. Aboriginal patterns of cancer care (APOCC) in New South Wales: an update. Invited presentation. COSA – IACR 2008 Joint Scientific Meeting Sydney 18-20 November 2008.

40. O’Connell D. Cancer Screening. Invited Speaker. Consumer Research Training. Cancer Council, NSW August 2009.

41. O’Connell D. ABC Women’s Health Study. Invited Speaker. Cancer Council NSW Epi Hour September 2009.

42. O'Connell DL, Carmichael LK, Smith DP, Gattellari M, Chambers S, Pinnock CP, Slevin T, Ward J. Prostate cancer and PSA testing. How much do men think they know? What do they know? Invited oral presentation at Primary Care Collaborative Cancer Clinical Trials Group 1st Scientific Meeting. Melbourne, Australia, 2010.

2011- 43. O’Connell DL. Recruiting representative samples in population-based patterns of care

studies. Invited Speaker. NSW/ACT Cancer Epidemiology Network Meeting, Sydney, April 2011.

44. O’Connell DL. Academic pathway. Overview and career journey. Post-graduate and Early Career Research Symposium. Invited speaker. NSW/ACT Cancer Epidemiology Network Meeting, Sydney, September 2011.

Research Support

1987-1990 1. Heller RF, Roberts DC, O’Connell DL. Response of blood cholesterol to diet change in

twins. National Health and Medical Research Council, Australia, 1987-88 $39,752 per year.

2. O’Connell DL, Heller RF. Reproductive history and myocardial infarction in women: A case control study. National Heart Foundation, Australia, 1988-89 $17,000 per year.

3. Heller RF, O’Connell DL, Boulton TJC. Risk factor reduction among families of those with ischaemic heart disease. National Health and Medical Research Council, Australia, 1989 $50,694.

4. Parsons C, O’Connell DL. Lay perceptions of screening and risk. National Health and Medical Research Council, Australia, 1989 $43,000.

5. Sanson-Fisher RW, O’Connell DL, Sutherland DC. Randomised trial of programs to modify AIDS risk behaviours in adolescents. National Health and Medical Research Council Commonwealth Aids Research Grants Committee, Australia, 1989-91 $52,651 per year.

6. Henry DA, Mitchell AS, O’Connell DL. Monitoring the safety of therapeutic drugs using consumer reports. National Health and Medical Research Council, Australia, 1990-91 $44,500 (1990), $35,000 (1991).

7. O’Connell DL. The analysis of twin studies: a comparison of statistical methods. The University of Newcastle Research Committee, 1990 $5,813.

1991-2000 8. O’Connell DL, Kinlay J. Mastitis in breastfeeding. Health, Housing and Community

Services Research and Development Grants, Australia, 1994 $23,649.


9. Henry D, O’Connell D. Analysis on prescribing for major groups of prescription pharmaceuticals which might explain the variability in prescribing rates and total prescription costs incurred by general practitioners. General Practice Branch, Commonwealth Department of Human Services and Health, 1994-95 $48,632.

10. Henry DA, O’Connell DL, Sackett D, Glasziou P, Lowe JM. Assessing and increasing generalisability of RCTs. NHS Health Technology Assessment Programme, Department of Health, United Kingdom, 1996 $107,448.

11. Henry DA, O’Connell DL, Robertson J. The validation, testing and analysis of prescribing indicators and provision of analyses of divisional prescribing data to divisions. General Practice Branch, Commonwealth Department of Health and Family Services, 1997 $78,250.

12. Henry DA, O’Connell DL. Value of non-randomised studies for assessing the effectiveness of medical interventions. National Health and Medical Research Council, Australia, 1997 $45,679, 1998 $24,070.

13. Henry DA, O’Connell DL, Hill SR. The effect of different forms of information framing on health care practices. National Health and Medical Research Council, Australia, 1998 $60,771, 1999 $63,550.

14. Henry DA, O’Connell DL, Hill SR, Lowe JM. Improving treatment decisions: accurate generalisation of clinical trial results. National Health and Medical Research Council, Australia, 1998 $25,323, 1999 $24,905.

15. O’Connell D, Glasziou P, Hill S. Draft of guidelines on how to use the evidence (scientific information). Health Advisory Committee, National Health and Medical Research Council, Australia, 1998 $29,884.

16. O’Connell D, Lowe J, Candlish P. Exercise rehabilitation in patients with congestive heart failure. A systematic review. Astra Pharmaceuticals, Australia, 1999 $27,301.

17. Henry D, Hill S, O’Connell D, Glasziou P. Evaluation of the Integrated Care Program. The Pharmaceutical Partnership, 1999 $150,000.

18. Henry D, O’Connell D, Deveridge D. Alternatives to homologous blood transfusion – development of evidence-based decision aids. National Health and Medical Research Council, Australia, 2000 $116,733, 2001 $96,964.

19. O’Connell D. Local evaluation of the Maitland After Hours Care Trial. Hunter Urban Division of General Practice and Commonwealth Department of Health and Aged Care, 1999-2000 $42,952.

2001-2010 20. Armstrong BK, Jorm LR, Taylor RJ, Kricker A, Mattick RP, O’Connell DL, Roberts CL,

Simpson JM, Sullivan EA, Zwi AB. HERON: using population health data to improve health services, policy and planning. NHMRC Capacity Building Grants in Population Health Research. 2003/04-2007/08 $2.5m.

21. O’Connell D, Smith D, Ward J, Steginga S, Pinnock C. PSA testing: a population-based longitudinal study of decision making, psychological effects and patterns of care. National Health and Medical Research Council, Australia, Project Grant. 2005 $199,330, 2006 $255,563, 2007 $117,738.

22. Sitas F, O’Connell D, Banks E, Frazer I. The effect of exogenous hormones, smoking and HPV on the incidence of screen detected pre-invasive cervical cancer. National Health and Medical Research Council, Australia, Project Grant. 2006 $235,675, 2007 $230,675, 2008 $228,425, 2009 $228,425, 2010 $228,425.

23. O’Connell D, Smith D. Patterns of care studies for prostate, lung and colorectal cancers. Cancer Institute NSW. 2006 $150,000.

24. Marshall V, Reeve T, Pinnock C, Smith D, O’Connell D. Development of clinical practice guidelines for metastatic prostate cancer. Andrology Australia. 2006-08 $117,320.

25. Marshall V, Reeve T, Pinnock C, Smith D, O’Connell D. Development of clinical practice guidelines for metastatic prostate cancer. Prostate Cancer Foundation of Australia. 2006-07 $59,188.


26. O’Connell D, Butow P, Armstrong B, et al. Patterns of cancer care for Indigenous people in NSW. NHMRC Health Services Research Round 3 2007-11 $1,580,755.

27. Canfell K, Sitas F, Barnabas R, Garnett G, Beral V, Clements M, O’Connell D. Optimising cervical screening after the introduction of HPV vaccination in Australia: modelling of outcomes. National Health and Medical Research Council, Australia, Project Grant. 2007 $117,292, 2008 $96,200, 2009 $91,200.

28. Ward RL, Pearson S-A, Haas M, O’Connell DL, McKinnon RA, Henry DA. Establishment of a network to evaluate new and emerging cancer therapies. Cancer Australia Priority-driven Collaborative Research Scheme. 2008 $200,000, 2009 $200,000, 2010 $200,000.

29. Harris MF, Spigelman AD, O’Connell DL, Barton MB, Veitch C. Referral pathways in colorectal cancer: general practitioners’ patterns of referral and factors that influence referral. Cancer Australia Priority-driven Collaborative Research Scheme. 2008 $200,000, 2009 $200,000, 2010 $198,750.

30. O'Connell D, Chambers S, Moxey A, Smith D. Use of complementary and lifestyle therapies by men with prostate cancer: a population-based study. Prostate Cancer Foundation of Australia. 2009-2011 $137,766.

31. Marshall V, Reeve T, Pinnock C, Smith D, O’Connell D. Development of clinical practice guidelines for metastatic prostate cancer. Prostate Cancer Foundation of Australia. 2009 $43,000.

32. O’Connell D. Developing, promulgating and assessing treatment algorithms for the management of lung cancer in NSW. Cancer Institute NSW. 2009-10 $69,060.

33. Neale R, O’Connell D, Janda M, Merrett N, Goldstein D, Beesley V. Patterns of care and quality of life in patients with pancreatic cancer. NHMRC Project Grant. 2010-2012 $655,213.

2011- 34. Clements M, Smith D, O’Connell D, Etzioni R, Gardiner R. Testing and Treatment for

Prostate Cancer in Australia: Epidemiology and Modelling. NHMRC Project Grant. 2011-2013. $518,390.

35. O’Connell D, Supramaniam R, Dillon A, Ingham J, Fernando P. Cancer Comorbidity, Treatment, Survival and End of Life Care for Aboriginal People in NSW. Cancer Institute NSW Cancer Epidemiology Linkage Grant. 2011-2013. $280,688.

36. Haines M, O’Connell D, Young J, Smith D, Kneebone A, Brooks A, Watt H. Improving evidence based care for locally advanced prostate cancer – a randomised phased trial of clinical guideline implementation through a clinical network. NHMRC Partnership Project Grant. 2011-2013. $533,442 NHMRC, $537,674 PCFA.

37. Chambers S, Baade P, Youl P, Aitken J, Dunn J, Garvey G, Valery P, O’Connell D. The effects of stigma and nihilistic views on lung cancer outcomes. Cancer Australia RFT. 2011-12. $588,112.

38. Ingham J, O’Connell D, Phillips J, Davidson P, Girgis A, Wilkinson A, Piza M, Pigot M, Goldsbury D. Last days of life linkage study: patterns of health services use and experiences of adult NSW residents in the year prior to death from illness. Cancer Institute NSW. 2011-12. $83,748.

Teaching

Undergraduate Faculty of Medicine, University of Newcastle 1987-88, 1990-91 Critical Reasoning for Medical students Years 1 and 2 1988, 1992-94 Statistical issues in the Year 2 Population Medicine projects 1989 Problem solving tutor, Year 1 Medicine Department of Statistics, University of Newcastle 1987-94 Lecturer for Analysis of Categorical Data in Statistics IV


1991, 2000 Lecturer for Statistical Consulting in Statistics IV 1992-94 Lecturer for one topic (Determination of Sample Size) in Advanced

Topics in Statistics in Statistics IV 2000 Lecturer for Surveys and Experiments in Statistics III/IV

Postgraduate Department of Biostatistics, School of Public Health, University of North Carolina at Chapel Hill, USA 1984 Course assistant for the graduate course, ‘Statistical Methods in the

Epidemiology of Infectious Diseases’ taught by Dr. B.G. Greenberg 1984 Part-time lecturer in the graduate course ‘Elements of Probability and

Statistical Inference’ Centre for Clinical Epidemiology and Biostatistics, University of Newcastle 1985-1994 Biostatistics. Teaching and course coordination Statistical Computing Journal Club Protocol Development 1991-1994 Master of Medical Statistics. Course Coordinator Supervision:

4 Masters of Medical Science in Clinical Epidemiology 10 Diploma in Medical Statistics Projects 3 Masters of Medical Statistics

Discipline of Clinical Pharmacology, University of Newcastle 1995-2000 Co-supervisor: 3 PhD candidates Cancer Council NSW 2001- 2010 2011-

Co-supervisor: 2 PhD candidates Supervisor: 1 MBiostats project placement student Primary supervisor: 1 PhD candidate

Workshops 1980-1990 1. Tutor at Annual Workshop in Clinical Epidemiology and Health Services Research

organised jointly by University of Newcastle, Westmead Hospital, University of Sydney and Macquarie University, 1979-80, 1985-88.

2. Tutor at Course in Advanced Community Health Research Methodology. Funded by the Ford Foundation and the Rockefeller Foundation. Thailand, 1988 and Indonesia, 1989.

3. Invited tutor at workshop on Statistical Methods in Medical Research held at Ramathibodi Hospital, Mahidol University, Bangkok Thailand November 1990. Presentations on Biostatistical Problems in Health Research and An Overview of Available Methods in Multivariable Analysis.

1991-2000 4. Invited tutor at workshop on Statistics for Clinicians held at Siriraj Hospital, Mahidol

University, Bangkok, Thailand June 1991. Presentations on An Introduction to Biostatistics and Data Analysis: Use of Descriptive Statistics and The Determination of Sample Size.

5. Co-tutor and one of the organisers for a workshop "Research Methods in Reproductive Epidemiology". Sponsored by The World Health Organization Human Reproduction Programme. Developed and presented teaching material on statistical inference,


sample size and exercises on statistical computing using data sets collected in Vietnam. Ho Chi Minh City, Vietnam 8-14 July 1993.

6. Co-tutor at workshop on The Use of Case-control Studies in Estimating Vaccine Efficacy. Therapeutic Goods Administration, Department of Human Services and Health, Canberra 4 September 1995.

7. Tutor for two workshops for pharmaceutical industry, Educational Workshop on the 1995 PBAC Guidelines, Melbourne August 1996, Sydney, October 1996.

8. Tutor for workshop on Applicability of Reviews and Trials. 4th International Cochrane Colloquium, Adelaide, October 1996.

9. Tutor for workshop on An Introduction to Statistical Methods for Pooling Data. 4th International Cochrane Colloquium, Adelaide, October 1996.

10. Convenor and tutor for workshop on Applicability of Reviews and Trials. 5th International Cochrane Colloquium, Amsterdam, October 1997.

11. Statistical Methods for Pharmaco-economics. Short Course in Pharmaco-economics, Newcastle November 1998.

12. Tutor for workshop on Applicability of Reviews and Trials - Introductory and Advanced. 6th International Cochrane Colloquium, Baltimore, October 1998.

13. Convenor and tutor for workshop on Applicability of Reviews and Trials. 7th International Cochrane Colloquium, Rome, October 1999.

14. Tutor for workshop on Applicability of Reviews and Trials of Complex Interventions. 7th International Cochrane Colloquium, Rome, October 1999.

2001-2010 15. O’Connell DL, D’Este C. Statistical Methods for Studies Involving Longitudinal Data

Collection. Workshop at the conference on Behavioural Research in Cancer Control: Towards the Future, Newcastle, April 2002.

16. Conducted workshop on Evidence-based Practice for Program Development Unit, Health Development Division, The Cancer Council NSW May-June 2003 and Health Strategies Division, The Cancer Council NSW August 2004.

17. Organiser. COSA-IACR Workshop on advanced methods for the analysis of cancer registry data, Sydney November 2008.

curriculum vitae - mail :: welcome to horde · curriculum vitae - dianne o’connell – january...

Documents